Rahbar Reza, Litrovnik Biana G, Vargas Sara O, Robson Caroline D, Nuss Roger C, Irons Mira B, McGill Trevor J, Healy Gerald B
Department of Otolaryngology and Communication Disorders, Children's Hospital, Harvard Medical School, Boston, Mass, USA.
Arch Otolaryngol Head Neck Surg. 2004 Dec;130(12):1400-6. doi: 10.1001/archotol.130.12.1400.
To review the presentation of laryngeal neurofibroma, including its association with neurofibromatosis types 1 and 2, and present guidelines for its management.
Retrospective study.
Five pediatric patients with laryngeal neurofibroma, 4 girls (80%) and 1 boy (20%), were treated at a tertiary pediatric medical center from 1973 through 2003. Recorded data included age at initial presentation, sex, symptoms, significant medical and family history, preoperative evaluation, location of the tumor, surgical procedure, complications, outcome, and recurrence.
The 5 patients presented with stridor and cafe-au-lait spots at or shortly after birth. All patients were diagnosed as having neurofibromatosis type 1 by the established criteria. Studies evaluating the disease processes included plain radiography, computerized tomography, magnetic resonance imaging, barium swallow, and laryngoscopy and bronchoscopy under anesthesia. Pathologic examination of biopsy specimens from all patients showed neurofibromas with plexiform and/or diffuse features. Treatments included tracheotomy (n = 4), carbon dioxide laser excision (n = 4), modified neck dissection (n = 3), partial pharyngectomy (n = 1), supraglottic laryngectomy (n = 1), and endoscopic hemilaryngectomy (n = 1). Three patients were successfully decannulated. Follow-up ranged from 1 to 15 years. One patient was lost to follow-up. No evidence of malignant degeneration was noted.
Neurofibroma of the larynx is a rare condition that should be considered in the differential diagnosis of children with a submucosal laryngeal mass. In our series, all patients had associated neurofibromatosis type 1. Complete surgical excision is the treatment of choice in cases of localized small lesions. To prevent debilitating outcomes due to aggressive surgery, minimally invasive procedures (partial excision via endoscopic approach) may be preferable for larger lesions that infiltrate the surrounding vital structures. Long-term follow up of these patients is essential owing to the possibility of malignant transformation.
回顾喉神经纤维瘤的临床表现,包括其与1型和2型神经纤维瘤病的关联,并提出其治疗指南。
回顾性研究。
1973年至2003年期间,一家三级儿科医疗中心收治了5例患有喉神经纤维瘤的儿科患者,其中4名女孩(80%)和1名男孩(20%)。记录的数据包括初次就诊时的年龄、性别、症状、重要的病史和家族史、术前评估、肿瘤位置、手术方式、并发症、结果及复发情况。
5例患者在出生时或出生后不久出现喘鸣和咖啡牛奶斑。所有患者均根据既定标准被诊断为1型神经纤维瘤病。评估疾病进程的检查包括X线平片、计算机断层扫描、磁共振成像、吞钡检查以及在麻醉下进行的喉镜和支气管镜检查。所有患者活检标本的病理检查均显示为具有丛状和/或弥漫性特征的神经纤维瘤。治疗方法包括气管切开术(4例)、二氧化碳激光切除术(4例)、改良颈部清扫术(3例)、部分咽切除术(1例)、声门上喉切除术(1例)和内镜半喉切除术(1例)。3例患者成功拔管。随访时间为1至15年。1例患者失访。未发现恶性变的证据。
喉神经纤维瘤是一种罕见疾病,在鉴别诊断患有喉黏膜下肿物的儿童时应予以考虑。在我们的系列研究中,所有患者均伴有1型神经纤维瘤病。对于局限性小病变,完整手术切除是首选治疗方法。为防止因激进手术导致的不良后果,对于浸润周围重要结构的较大病变,微创治疗(通过内镜途径部分切除)可能更为可取。鉴于存在恶变的可能性,对这些患者进行长期随访至关重要。